Literature DB >> 28404156

Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Sawan Bopanna1, Ashwin N Ananthakrishnan2, Saurabh Kedia1, Vijay Yajnik2, Vineet Ahuja3.   

Abstract

BACKGROUND: The increased risk of colorectal cancer in ulcerative colitis is well known. The risk of sporadic colorectal cancer in Asian populations is considered low and risk estimates of colorectal cancer related to ulcerative colitis from Asia vary. This meta-analysis is an Asian perspective on the risk of colorectal cancer related to ulcerative colitis.
METHODS: We searched PubMed and Embase for terms related to colorectal cancer in ulcerative colitis from inception to July 1, 2016. The search for published articles was done by country for all countries in Asia. We included studies with information on the prevalence and cumulative risk of colorectal cancer at various timepoints. A random-effects meta-analysis was done to calculate the pooled prevalence as well as a cumulative risk at 10 years, 20 years, and 30 years of disease.
FINDINGS: Our search identified 2575 articles; of which 44 were eligible for inclusion. Our analysis included a total of 31 287 patients with ulcerative colitis with a total of 293 reported colorectal cancers. Using pooled prevalence estimates from various studies, the overall prevalence was 0·85% (95% CI 0·65-1·04). The risks for colorectal cancer were 0·02% (95% CI 0·00-0·04) at 10 years, 4·81% (3·26-6·36) at 20 years, and 13·91% (7·09-20·72) at 30 years. Subgroup analysis by stratifying the studies according to region or period of the study did not reveal any significant differences.
INTERPRETATION: We found the risk of colorectal cancer in Asian patients with ulcerative colitis was similar to recent estimates in Europe and North America. Adherence to screening is therefore necessary. Larger population-based, prospective studies are required for better estimates of the risk. FUNDING: Indo-US Science and Technology Forum.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28404156      PMCID: PMC5713894          DOI: 10.1016/S2468-1253(17)30004-3

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  51 in total

1.  Clinical features and natural history of ulcerative colitis in Korea.

Authors:  Sang Hyoung Park; Young Min Kim; Suk-Kyun Yang; Sai-Hui Kim; Jeong-Sik Byeon; Seung-Jae Myung; Yun Kyung Cho; Chang-Sik Yu; Kwi-Sook Choi; Jun-Won Chung; Benjamin Kim; Kee Don Choi; Jin-Ho Kim
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

2.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation among Malaysian patients.

Authors:  Yan-Mei Tan; Khean-Lee Goh
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

4.  Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.

Authors:  Tine Jess; Jacob Simonsen; Kristian Tore Jørgensen; Bo Vestergaard Pedersen; Nete Munk Nielsen; Morten Frisch
Journal:  Gastroenterology       Date:  2012-04-19       Impact factor: 22.682

5.  Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.

Authors:  Takayoshi Fujita; Takafumi Ando; Osamu Watanabe; Motofusa Hasegawa; Nobuyuki Miyake; Shinya Kondo; Tsuyoshi Kato; Kazuhiro Ishiguro; Masanao Nakamura; Ryoji Miyahara; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  Hepatogastroenterology       Date:  2010 May-Jun

6.  Low incidence of colorectal dysplasia and cancer among patients with ulcerative colitis: a Turkish referral centre study.

Authors:  Murat Kekilli; Ulku Dagli; Ismail Hakki Kalkan; Bilge Tunc; Selcuk Disibeyaz; Aysel Ulker; Burhan Sahin
Journal:  Scand J Gastroenterol       Date:  2010-04       Impact factor: 2.423

7.  [Dysplasia in ulcerative colitis detected by surveillance colonoscopy].

Authors:  K Suzuki; T Muto; S Agawa; Y Morioka
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1991-04

8.  Colorectal carcinoma in Indian patients with idiopathic ulcerative colitis.

Authors:  R Kochhar; M K Goenka; S P Kaushik; N M Gupta; B Nagi; S K Mehta
Journal:  Eur J Cancer Prev       Date:  1992-06       Impact factor: 2.497

9.  Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population.

Authors:  K Hata; T Watanabe; S Kazama; K Suzuki; M Shinozaki; T Yokoyama; K Matsuda; T Muto; H Nagawa
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

10.  The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature.

Authors:  Sudul Mananjala Senanayake; Anthony Nilesh Ranjeev Fernandopulle; Madunil Anuk Niriella; Nethini Thilanga Wijesinghe; Amanda Ranaweera; Mohammadu Nisar Mufeena; Arunasalam Pathmeswaran; Nawarathnelage Meththananda Nawarathne; Arjuna Priyadarsin de Silva; Hithanadura Janaka de Silva
Journal:  Clin Exp Gastroenterol       Date:  2013-09-20
View more
  54 in total

1.  Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.

Authors:  Ya-Lan Dong; Xue-Yun Duan; Yu-Jin Liu; Heng Fan; Meng Xu; Qian-Yun Chen; Zhen Nan; Hui Wu; Shuang-Jiao Deng
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

2.  Luteolin alleviates ulcerative colitis through SHP-1/STAT3 pathway.

Authors:  Bo-Lin Li; Dan-Yang Zhao; Peng-Li Du; Xiao-Tian Wang; Qian Yang; Yan-Ru Cai
Journal:  Inflamm Res       Date:  2021-05-20       Impact factor: 4.575

3.  Exposure time determines the protective effect of Trichinella spiralis on experimental colitis.

Authors:  Wenxiao Zheng; Zhenrong Ma; Xi Sun; Yehong Huang; Bin Lu; Xiaogang Chen; Xiang Xue; Xuexian Yang; Xiang Wu
Journal:  Microb Pathog       Date:  2020-05-20       Impact factor: 3.738

4.  CircRNAs as promising biomarkers of inflammatory bowel disease and its associated-colorectal cancer.

Authors:  Yuting Xu; Xinwei Xu; Dickson Kofi Wiredu Ocansey; Hua Cao; Wei Qiu; Qiang Tu; Fei Mao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

5.  Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.

Authors:  Gang Wang; Qian Wang; Yongguo Fan; Xianli He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  The combined efficacy of adalimumab with GMA method on the treatment of ulcerative colitis and repair of intestinal mucosal lesion.

Authors:  Ailing Song; Hai Jiang; Liang Guo; Shanshan Wu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 7.  Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?

Authors:  Mostafa Vaghari-Tabari; Davoud Jafari-Gharabaghlou; Fatemeh Sadeghsoltani; Parisa Hassanpour; Durdi Qujeq; Nadereh Rashtchizadeh; Amir Ghorbanihaghjo
Journal:  Biol Trace Elem Res       Date:  2020-10-23       Impact factor: 3.738

8.  African-Americans and Indigenous Peoples Have Increased Burden of Diseases of the Exocrine Pancreas: A Systematic Review and Meta-Analysis.

Authors:  Aya Cervantes; Ellen K Waymouth; Maxim S Petrov
Journal:  Dig Dis Sci       Date:  2018-09-27       Impact factor: 3.199

9.  Identification of potential biomarkers and pathways in ulcerative colitis with combined public mRNA and miRNA expression microarray data analysis.

Authors:  Lili Yang; Yaoyao Bian; Zhengjun Li; Yan Yan; Junyi Li; Wenlin Li; Li Zeng
Journal:  J Gastrointest Oncol       Date:  2019-10

Review 10.  Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Inflamm Intest Dis       Date:  2017-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.